- Featured Product
- KD/KO Validated
CoraLite® Plus 594-conjugated PGAM1 Monoclonal antibody
PGAM1 Monoclonal Antibody for IF
Host / Isotype
Mouse / IgG1
Reactivity
Human, Mouse, Rat
Applications
IF/ICC
Conjugate
CoraLite® Plus 594 Fluorescent Dye
CloneNo.
2H2A9
Cat no : CL594-67470
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL594-67470 targets PGAM1 in IF/ICC applications and shows reactivity with Human, Mouse, Rat samples.
Tested Reactivity | Human, Mouse, Rat |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | PGAM1 fusion protein Ag9250 |
Full Name | phosphoglycerate mutase 1 (brain) |
Calculated Molecular Weight | 254 aa, 29 kDa |
Observed Molecular Weight | 29 kDa |
GenBank Accession Number | BC011678 |
Gene Symbol | PGAM1 |
Gene ID (NCBI) | 5223 |
Conjugate | CoraLite® Plus 594 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 594 nm / 615 nm |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
PGAM1(phosphoglycerate mutase 1) is also named as PGAMA,PGAM-B and belongs to the phosphoglycerate mutase family. Phosphoglycerate mutase is widely distributed in mammalian tissues where it catalyzes the reversible reaction of 3-phosphoglycerate (3-PGA) to 2-phosphoglycerate (2-PGA) in the glycolytic pathway. The homodimer PGAM1 is expressed mainly in liver, kidney, brain and overexpressed in a variety of human cancers, including breast carcinoma, colorectal cancer, lung cancer, prostate cancer, oral squamous cell carcinoma, esophageal squamous cell carcinomas and also associated with certain virus infection. PGAM1 could be developed as a useful diagnostic biomarker, as well as a potential therapeutic target for hepatocellular carcinoma (PMID:20403181). This antibody may also recognize PGAM2 and PGAM4 due to the high homology.
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 594 PGAM1 antibody CL594-67470 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |